202425 Feb

Abridge Receives Additional $150M Investment

Summary

Abridge, a Pittsburgh, PA-based company which specializes in generative AI for clinical documentation, received an additional $150M investment. The company intends to use the funds to expand the team and develop foundation models that draw upon vast troves of multimodal healthcare data. Led by Dr. Shiv Rao, CEO and Founder, Abridge provides a platform that was purpose-built for medical conversations, improving clinical documentation efficiencies while enabling clinicians to focus on their patients. The company is actively developing novel ways to personalize notes, integrate more deeply into the EMR, and provide clinicians with after-visit insights. The initial deployment will be focused on reducing the cognitive burden of clinical documentation, enabling clinicians to spend more face-to-face time engaging with patients instead of computers.

Source: Finsmes

Funding

$150M
Amount
Feb 25 2024
Date
-
Investor
-
Company

Classifications

Companies